| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
John Way last filed a Form 4 in February 2021, as Chief Financial Officer at PRLB. John Way's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 33,657 shares of PRLB. The PRLB filings lean toward selling, a net 27,863 shares.
John Way has 16 Form 4 filings on record from February 2015 to February 2021, all as Chief Financial Officer at Proto Labs (PRLB), 2015–2021.
The 34 reported transactions were 7 tax withholdings, 7 stock awards, 7 option or other derivative awards and 7 open-market sales, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $3.9M.
The largest open-market sale was 15,951 shares of PRLB at an average $131.61 on August 6, 2020, about $2.1M.
Shares as reported in the last Form 4 for each company; the most recent is from February 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2020 | PRLB Proto Labs Inc | Chief Financial Officer | Sale+OE | 15,951 | $131.61 | $2,099,245.09 | -33.9% | |
| Sep 24, 2018 | PRLB Proto Labs Inc | Chief Financial Officer | Sale+OE | 8,000 | $159.10 | $1,272,796.16 | -23.9% | |
| Aug 24, 2018 | PRLB Proto Labs Inc | Chief Financial Officer | Sale+OE | 3,912 | $145.79 | $570,336.94 | -13.3% |